Please wait a minute...
Frontiers of Chemical Science and Engineering

ISSN 2095-0179

ISSN 2095-0187(Online)

CN 11-5981/TQ

Postal Subscription Code 80-969

2018 Impact Factor: 2.809

Front. Chem. Sci. Eng.    2023, Vol. 17 Issue (12) : 1866-1878    https://doi.org/10.1007/s11705-023-2340-x
REVIEW ARTICLE
Anti-biofouling strategies for implantable biosensors of continuous glucose monitoring systems
Yan Zheng1, Dunyun Shi2, Zheng Wang1()
1. School of Pharmaceutical Science & Technology, Tianjin University, Tianjin 300072, China
2. Institute of Hematology, Shenzhen Second People’s Hospital/the First Affiliated Hospital of Shenzhen University, Shenzhen 518035, China
 Download: PDF(4420 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

Continuous glucose monitoring (CGM) systems play an increasingly vital role in the glycemic control of patients with diabetes mellitus. However, the immune responses triggered by the implantation of poorly biocompatible sensors have a significant impact on the accuracy and lifetime of CGM systems. In this review, research efforts over the past few years to mitigate the immune responses by enhancing the anti-biofouling ability of sensors are summarized. This review divided these works into active immune engaging strategy and passive immune escape strategy based on their respective mechanisms. In each strategy, the various biocompatible layers on the biosensor surface, such as drug-releasing membranes, hydrogels, hydrophilic membranes, anti-biofouling membranes based on zwitterionic polymers, and bio-mimicking membranes, are described in detail. This review, therefore, provides researchers working on implantable biosensors for CGM systems with vital information, which is likely to aid in the research and development of novel CGM systems with profound anti-biofouling properties.

Keywords implantable glucose biosensor      anti-biofouling      continuous glucose monitoring      immune responses     
Corresponding Author(s): Zheng Wang   
Just Accepted Date: 21 June 2023   Online First Date: 11 September 2023    Issue Date: 30 November 2023
 Cite this article:   
Yan Zheng,Dunyun Shi,Zheng Wang. Anti-biofouling strategies for implantable biosensors of continuous glucose monitoring systems[J]. Front. Chem. Sci. Eng., 2023, 17(12): 1866-1878.
 URL:  
https://academic.hep.com.cn/fcse/EN/10.1007/s11705-023-2340-x
https://academic.hep.com.cn/fcse/EN/Y2023/V17/I12/1866
Fig.1  Schematic illustration of anti-biofouling strategies employed in membranes of biosensors for continuous glucose monitoring systems.
Anti-biofouling strategiesBiocompatible coatingsBiomaterialsCharactersDisadvantagesRefs.
Active immune engaging strategyAnti-inflammatory drugs releasing coatingDexamethasoneEffective inhibition of immune responseInhibition of vascularization[42]
NO releasing coatingNOEffective inhibition of immune responseChange of membrane microstructure[43]
Passive immune escape strategyHydrogelsAlginate, chitosanGood film-forming propertyPremature biodegradation and low mechanical strength[4446]
Polyethylene glycol (PEG)Good hydrophilicity, good film-forming propertyOxidative degradation and specific immune responses[47]
Hydrophilic membranesAlginate, chitosanGood film-forming propertyPremature biodegradation and low mechanical strength[48]
Polyurethane (PU)Suitable porosity, good biocompatibilityPoor immunogenicity and hydrophilicity[49]
PEGGood hydrophilicity, good film-forming propertyOxidative degradation and specific immune responses[50,51]
Efficient anti-biofouling membraneZwitterionic polymersExcellent hydrophilicity, efficient anti-biofouling ability[52,53]
Bio-mimicking membranesGelatin, collagenLow immunogenicityPremature biodegradation and low mechanical strength[54,55]
Tab.1  Various anti-biofouling biomaterials applied for implantable biosensor application
Fig.2  Schematic illustration of the formation of the alginate hydrogel on the surface of the glucose sensor via electrodeposition (the blue curly lines represent alginate). (a) Water electrolysis produces H+ ions, which promotes the release of Ca2+, and (b) the alginate hydrogel is formed by combining Ca2+ with alginate. Reprinted with permission from Ref. [44], copyright 2017, Elsevier.
Fig.3  Schematic illustration depicting the formation of the chitosan hydrogel on the CeO2/MnO2 hollow nanospheres contained with Gox. Reprinted with permission from Ref. [46], copyright 2020, Elsevier.
Fig.4  Schematic illustration depicting the formation of (a) PEG hydrogel and (b) alginate hydrogel by using different methods. Reprinted with permission from Ref. [47], copyright 2023, Royal Society of Chemistry.
Fig.5  Fabrication of an adaptable, controllable, porous outer membrane for an implantable glucose biosensor by using a “top-down” method. Chitosan and sodium alginate were used for constructing biocompatible interfaces. Reprinted with permission from Ref. [48], copyright 2019, American Chemical Society.
Fig.6  (a) Schematic representation of the glucose sensor. (b) Photographic image of the glucose sensor. (c) Schematic illustration of the electrospraying process. Reprinted with permission from Ref. [51], copyright 2021, American Chemical Society.
Fig.7  Schematic illustration of the formation of hydration shell. (a) Each unit of the representative PEG materials is integrated with one water molecule. (b) Each unit of the zwitterionic materials is integrated with eight water molecules. Reprinted with permission from Ref. [112], copyright 2016, Elsevier.
Fig.8  Schematic illustration depicting the preparation of the Pt-pANi-GOx-pSBMA glucose biosensor coated with a zwitterionic polymer. Reprinted with permission from Ref. [52], copyright 2016, American Chemical Society.
Fig.9  (a) Schematic illustration of coil-type glucose biosensor with biomimetic electrospun coatings containing gelatin. Reprinted with permission from Ref. [54], copyright 2017, John Wiley and Sons. (b) Schematic illustration depicting the construction of implantable glucose biosensor based on type I collagen-derived conductive hydrogel. Reprinted with permission from Ref. [55], copyright 2019, American Chemical Society.
1 K Ogurtsova, J D da Rocha Fernandes, Y Huang, U Linnenkamp, L Guariguata, N H Cho, D Cavan, J E Shaw, L E Makaroff. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Research and Clinical Practice, 2017, 128: 40–50
https://doi.org/10.1016/j.diabres.2017.03.024
2 P Zimmet, K Alberti, J Shaw. Global and societal implications of the diabetes epidemic. Nature, 2001, 414(6865): 782–787
https://doi.org/10.1038/414782a
3 L Johnston, G Wang, K Hu, C Qian, G Liu. Advances in biosensors for continuous glucose monitoring towards wearables. Frontiers in Bioengineering and Biotechnology, 2021, 9: 733810
https://doi.org/10.3389/fbioe.2021.733810
4 D Timofte, A Mandita, A E Balcangiu-Stroescu, D Balan, L Raducu, M D Tanasescu, A Diaconescu, D Dragos, C I Cosconel, S M Stoicescu, D Ionescu. Hyperuricemia and cardiovascular diseases clinical and paraclinical correlations. Revista de Chimie, 2019, 70(3): 1045–1046
https://doi.org/10.37358/RC.19.3.7060
5 C S Fox, S H Golden, C Anderson, G A Bray, L E Burke, I H de Boer, P Deedwania, R H Eckel, A G Ershow, J Fradkin. et al.. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the american heart association and the american diabetes association. Diabetes Care, 2015, 38(9): 1777–1803
https://doi.org/10.2337/dci15-0012
6 A E B Stroescu, M D Tanasescu, A Diaconescu, L Raducu, D G Balan, A Mihai, M Tanase, I I Stanescu, D Ionescu. Diabetic nephropathy: a concise assessment of the causes, risk factors and implications in diabetic patients. Revista de Chimie, 2018, 69(11): 4018–4021
7 C Wanner, S E Inzucchi, B Zinman. Empagliflozin and progression of kidney disease in type 2 diabetes reply. New England Journal of Medicine, 2016, 375(18): 1801–1802
8 Y Cui, L Zhang, M Zhang, X Yang, L Zhang, J Kuang, G Zhang, Q Liu, H Guo, Q Meng. Prevalence and causes of low vision and blindness in a Chinese population with type 2 diabetes: the Dongguan eye study. Scientific Reports, 2017, 7(1): 11195
https://doi.org/10.1038/s41598-017-11365-z
9 A Mandita, D Timofte, A E Balcangiu-Stroescu, D Balan, L Raducu, M D Tanasescu, A Diaconescu, D Dragos, C I Cosconel, S M Stoicescu, D Ionescu. Treatment of high blood pressure in patients with chronic renal disease. Revista de Chimie, 2019, 70(3): 993–995
https://doi.org/10.37358/RC.19.3.7047
10 D A Mihai, D S Stefan, D Stegaru, G E Bernea, I A Vacaroiu, T Papacocea, M O D Lupusoru, A E Nica, O Stiru, D Dragos, O Olaru. Continuous glucose monitoring devices: a brief presentation. Experimental and Therapeutic Medicine, 2021, 23(2): 174
https://doi.org/10.3892/etm.2021.11097
11 D M Nathan, D E R Grp. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care, 2014, 37(1): 9–16
https://doi.org/10.2337/dc13-2112
12 O Didyuk, N Econom, A Guardia, K Livingston, U Klueh. Continuous glucose monitoring devices: past, present, and future focus on the history and evolution of technological innovation. Journal of Diabetes Science and Technology, 2021, 15(3): 676–683
https://doi.org/10.1177/1932296819899394
13 R M Bergenstal, J E Layne, H Zisser, R A Gabbay, N A Barleen, A A Lee, A R Majithia, C G Parkin, R F Dixon. Remote application and use of real-time continuous glucose monitoring by adults with type 2 diabetes in a virtual diabetes clinic. Diabetes Technology & Therapeutics, 2021, 23(2): 128–132
https://doi.org/10.1089/dia.2020.0396
14 N Mauras, L Fox, K Englert, R W Beck. Continuous glucose monitoring in type 1 diabetes. Endocrine, 2013, 43(1): 41–50
https://doi.org/10.1007/s12020-012-9765-1
15 G Cappon, M Vettoretti, G Sparacino, A Facchinetti. Continuous glucose monitoring sensors for diabetes management: a review of technologies and applications. Diabetes & Metabolism Journal, 2019, 43(4): 383–397
https://doi.org/10.4093/dmj.2019.0121
16 G M Pepper. Hemoglobin A1c values and CGM response. Diabetes Technology & Therapeutics, 2012, 14(10): 972
17 N Poolsup, N Suksomboon, A M Kyaw. Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes. Diabetology & Metabolic Syndrome, 2013, 5(1): 39
https://doi.org/10.1186/1758-5996-5-39
18 S J Fonda, C Graham, J Munakata, J M Powers, D Price, R A Vigersky. The cost-effectiveness of real-time continuous glucose monitoring (RT-CGM) in type 2 diabetes. Journal of Diabetes Science and Technology, 2016, 10(4): 898–904
https://doi.org/10.1177/1932296816628547
19 R A Vigersky, S J Fonda, M Chellappa, M S Walker, N M Ehrhardt. Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care, 2012, 35(1): 32–38
https://doi.org/10.2337/dc11-1438
20 S E Clarke, J R Foster. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. British Journal of Biomedical Science, 2012, 69(2): 83–93
https://doi.org/10.1080/09674845.2012.12002443
21 P J Taylor, C H Thompson, G D Brinkworth. Effectiveness and acceptability of continuous glucose monitoring for type 2 diabetes management: a narrative review. Journal of Diabetes Investigation, 2018, 9(4): 713–725
https://doi.org/10.1111/jdi.12807
22 S V Edelman. Regulation catches up to reality. Journal of Diabetes Science and Technology, 2017, 11(1): 160–164
https://doi.org/10.1177/1932296816667749
23 Y Zou, Z Chu, J Guo, S Liu, X Ma, J Guo. Minimally invasive electrochemical continuous glucose monitoring sensors: recent progress and perspective. Biosensors & Bioelectronics, 2023, 225: 115103
https://doi.org/10.1016/j.bios.2023.115103
24 O Moser, J Münzker, S Korsatko, C Pachler, K Smolle, W Toller, T Augustin, J Plank, T R Pieber, J K Mader. et al.. A prolonged run-in period of standard subcutaneous microdialysis ameliorates quality of interstitial glucose signal in patients after major cardiac surgery. Scientific Reports, 2018, 8(1): 1262
https://doi.org/10.1038/s41598-018-19768-2
25 T V Brennan, K E Lunsford, P C Kuo. Innate pathways of immune activation in transplantation. Journal of Transplantation, 2010, 2010: 826240
https://doi.org/10.1155/2010/826240
26 Z Sheikh, P J Brooks, O Barzilay, N Fine, M Glogauer. Macrophages, foreign body giant cells and their response to implantable biomaterials. Materials (Basel), 2015, 8(9): 5671–5701
https://doi.org/10.3390/ma8095269
27 S Toda, A Fattah, K Asawa, N Nakamura, K N Ekdahl, B Nilsson, Y Teramura. Optimization of islet microencapsulation with thin polymer membranes for long-term stability. Micromachines, 2019, 10(11): 755
https://doi.org/10.3390/mi10110755
28 Y J Heo, S Takeuchi. Towards smart tattoos: implantable biosensors for continuous glucose monitoring. Advanced Healthcare Materials, 2013, 2(1): 43–56
https://doi.org/10.1002/adhm.201200167
29 T Bobrowski, W Schuhmann. Long-term implantable glucose biosensors. Current Opinion in Electrochemistry, 2018, 10: 112–119
https://doi.org/10.1016/j.coelec.2018.05.004
30 M Elsherif, M U Hassan, A K Yetisen, H Butt. Glucose sensing with phenylboronic acid functionalized hydrogel-based optical diffusers. ACS Nano, 2018, 12(3): 2283–2291
https://doi.org/10.1021/acsnano.7b07082
31 J H Yuan, K Wang, X H Xia. Highly ordered platinum-nanotubule arrays for amperometric glucose sensing. Advanced Functional Materials, 2005, 15(5): 803–809
https://doi.org/10.1002/adfm.200400321
32 R Ahmad, N Tripathy, M S Ahn, K S Bhat, T Mahmoudi, Y Wang, J Y Yoo, D W Kwon, H Y Yang, Y B Hahn. Highly efficient non-enzymatic glucose sensor based on cuo modified vertically-grown ZnO nanorods on electrode. Scientific Reports, 2017, 7(1): 5715
https://doi.org/10.1038/s41598-017-06064-8
33 B N Kharbikar, G S Chendke, T A Desai. Modulating the foreign body response of implants for diabetes treatment. Advanced Drug Delivery Reviews, 2021, 174: 87–113
https://doi.org/10.1016/j.addr.2021.01.011
34 L A McKiel, K A Woodhouse, L E Fitzpatrick. The role of toll-like receptor signaling in the macrophage response to implanted materials. MRS Communications, 2020, 10(1): 55–68
https://doi.org/10.1557/mrc.2019.154
35 M T Novak, W M Reichert. Modeling the physiological factors affecting glucose sensor function in vivo. Journal of Diabetes Science and Technology, 2015, 9(5): 993–998
https://doi.org/10.1177/1932296815593094
36 P Vadgama. Monitoring with in vivo electrochemical sensors: navigating the complexities of blood and tissue reactivity. Sensors (Basel), 2020, 20(11): 3149
https://doi.org/10.3390/s20113149
37 U Klueh, J T Frailey, Y Qiao, O Antar, D L Kreutzer. Cell based metabolic barriers to glucose diffusion: macrophages and continuous glucose monitoring. Biomaterials, 2014, 35(10): 3145–3153
https://doi.org/10.1016/j.biomaterials.2014.01.001
38 C Li, C Guo, V Fitzpatrick, A Ibrahim, M J Zwierstra, P Hanna, A Lechtig, A Nazarian, S J Lin, D L Kaplan. Design of biodegradable, implantable devices towards clinical translation. Nature Reviews. Materials, 2019, 5(1): 61–81
https://doi.org/10.1038/s41578-019-0150-z
39 M Gray, J Meehan, C Ward, S P Langdon, I H Kunkler, A Murray, D Argyle. Implantable biosensors and their contribution to the future of precision medicine. Veterinary Journal (London, England), 2018, 239: 21–29
https://doi.org/10.1016/j.tvjl.2018.07.011
40 K A Jansen, P Atherton, C Ballestrem. Mechanotransduction at the cell-matrix interface. Seminars in Cell & Developmental Biology, 2017, 71: 75–83
https://doi.org/10.1016/j.semcdb.2017.07.027
41 I A Janson, A J Putnam. Extracellular matrix elasticity and topography: material-based cues that affect cell function via conserved mechanisms. Journal of Biomedical Materials Research. Part A, 2015, 103(3): 1246–1258
https://doi.org/10.1002/jbm.a.35254
42 B Gu, F Papadimitrakopoulos, D J Burgess. PLGA microsphere/PVA hydrogel coatings suppress the foreign body reaction for 6 months. Journal of Controlled Release, 2018, 289: 35–43
https://doi.org/10.1016/j.jconrel.2018.09.021
43 M J Malone-Povolny, T M Bradshaw, E P Merricks, C T Long, T C Nichols, M H Schoenfisch. Combination of nitric oxide release and surface texture for mitigating the foreign body response. ACS Biomaterials Science & Engineering, 2021, 7(6): 2444–2452
https://doi.org/10.1021/acsbiomaterials.1c00022
44 A Márquez, C Jimenez-Jorquera, C Dominguez, X Munoz-Berbel. Electrodepositable alginate membranes for enzymatic sensors: an amperometric glucose biosensor for whole blood analysis. Biosensors & Bioelectronics, 2017, 97: 136–142
https://doi.org/10.1016/j.bios.2017.05.051
45 N L Walker, J E Dick. Oxidase-loaded hydrogels for versatile potentiometric metabolite sensing. Biosensors & Bioelectronics, 2021, 178: 112997
https://doi.org/10.1016/j.bios.2021.112997
46 Z Liang, J Zhang, C Wu, X Hu, Y Lu, G Wang, F Yu, X Zhang, Y Wang. Flexible and self-healing electrochemical hydrogel sensor with high efficiency toward glucose monitoring. Biosensors & Bioelectronics, 2020, 155: 112105
https://doi.org/10.1016/j.bios.2020.112105
47 T J J Williams, A S S Jeevarathinam, F Jivan, V Baldock, P Kim, M J J McShane, D L L Alge. Glucose biosensors based on Michael addition crosslinked poly(ethylene glycol) hydrogels with chemo-optical sensing microdomains. Journal of Materials Chemistry. B, Materials for Biology and Medicine, 2023, 11(8): 1749–1759
https://doi.org/10.1039/D2TB02339C
48 J Zhou, Z Ma, X Hong, H M Wu, S Y Ma, Y Li, D J Chen, H Y Yu, X J Huang. Top-down strategy of implantable biosensor using adaptable, porous hollow fibrous membrane. ACS Sensors, 2019, 4(4): 931–937
https://doi.org/10.1021/acssensors.9b00035
49 X Jin, G Li, T Xu, L Su, D Yan, X Zhang. Fully integrated flexible biosensor for wearable continuous glucose monitoring. Biosensors & Bioelectronics, 2022, 196: 113760
https://doi.org/10.1016/j.bios.2021.113760
50 C Sun, J Miao, J Yan, K Yang, C Mao, J Ju, J Shen. Applications of antibiofouling PEG-coating in electrochemical biosensors for determination of glucose in whole blood. Electrochimica Acta, 2013, 89: 549–554
https://doi.org/10.1016/j.electacta.2012.11.005
51 R Feng, Y Chu, X Wang, Q Wu, F Tang. A long-term stable and flexible glucose sensor coated with poly(ethylene glycol)-modified polyurethane. Journal of Electroanalytical Chemistry (Lausanne, Switzerland), 2021, 895: 115518
https://doi.org/10.1016/j.jelechem.2021.115518
52 Y Hu, B Liang, L Fang, G Ma, G Yang, Q Zhu, S Chen, X Ye. Antifouling zwitterionic coating via electrochemically mediated atom transfer radical polymerization on enzyme-based glucose sensors for long-time stability in 37 degrees serum. Langmuir, 2016, 32(45): 11763–11770
https://doi.org/10.1021/acs.langmuir.6b03016
53 X Xie, J C Doloff, V Yesilyurt, A Sadraei, J J McGarrigle, M Omami, O Veiseh, S Farah, D Isa, S Ghani, I Joshi, A Vegas, J Li, W Wang, A Bader, H H Tam, J Tao, H Chen, B Yang, K A Williamson, J Oberholzer, R Langer, D G Anderson. Reduction of measurement noise in a continuous glucose monitor by coating the sensor with a zwitterionic polymer. Nature Biomedical Engineering, 2018, 2(12): 894–906
https://doi.org/10.1038/s41551-018-0273-3
54 K Burugapalli, S Wijesuriya, N Wang, W Song. Biomimetic electrospun coatings increase the in vivo sensitivity of implantable glucose biosensors. Journal of Biomedical Materials Research. Part A, 2018, 106(4): 1072–1081
https://doi.org/10.1002/jbm.a.36308
55 R Ravichandran, J G Martinez, E W H Jager, J Phopase, A P F Turner. Type I collagen-derived injectable conductive hydrogel scaffolds as glucose sensors. ACS Applied Materials & Interfaces, 2018, 10(19): 16244–16249
https://doi.org/10.1021/acsami.8b04091
56 B P Partlow, C W Hanna, J Rnjak-Kovacina, J E Moreau, M B Applegate, K A Burke, B Marelli, A N Mitropoulos, F G Omenetto, D L Kaplan. Highly tunable elastomeric silk biomaterials. Advanced Functional Materials, 2014, 24(29): 4615–4624
https://doi.org/10.1002/adfm.201400526
57 K N Ekdahl, J D Lambris, H Elwing, D Ricklin, P H Nilsson, Y Teramura, I A Nicholls, B Nilsson. Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies. Advanced Drug Delivery Reviews, 2011, 63(12): 1042–1050
https://doi.org/10.1016/j.addr.2011.06.012
58 T Papacocea, E Popa, T Dana, R Papacocea. The usefulness of dexamethasone in the treatment of chronic subdural hematomas. Farmacia, 2019, 67(1): 140–145
https://doi.org/10.31925/farmacia.2019.1.19
59 N G Welch, D A Winkler, H Thissen. Antifibrotic strategies for medical devices. Advanced Drug Delivery Reviews, 2020, 167: 109–120
https://doi.org/10.1016/j.addr.2020.06.008
60 A W Bridges, A J Garcia. Anti-inflammatory polymeric coatings for implantable biomaterials and devices. Journal of Diabetes Science and Technology, 2008, 2(6): 984–994
https://doi.org/10.1177/193229680800200628
61 D P Go, J A Palmer, S L Gras, A J O’Connor. Coating and release of an anti-inflammatory hormone from PLGA microspheres for tissue engineering. Journal of Biomedical Materials Research. Part A, 2012, 100A(2): 507–517
https://doi.org/10.1002/jbm.a.33299
62 R D Jayant, M J McShane, R Srivastava. In vitro and in vivo evaluation of anti-inflammatory agents using nanoengineered alginate carriers: towards localized implant inflammation suppression. International Journal of Pharmaceutics, 2011, 403(1–2): 268–275
https://doi.org/10.1016/j.ijpharm.2010.10.035
63 D Li, G Guo, R Fan, J Liang, X Deng, F Luo, Z Qian. PLA/F68/dexamethasone implants prepared by hot-melt extrusion for controlled release of anti-inflammatory drug to implantable medical devices: preparation, characterization and hydrolytic degradation study. International Journal of Pharmaceutics, 2013, 441(1–2): 365–372
https://doi.org/10.1016/j.ijpharm.2012.11.019
64 R Srivastava, R D Jayant, A Chaudhary, M J McShane. “Smart tattoo” glucose biosensors and effect of coencapsulated anti-inflammatory agents. Journal of Diabetes Science and Technology, 2011, 5(1): 76–85
https://doi.org/10.1177/193229681100500111
65 Y Wang, F Papadimitrakopoulos, D Burgess. J. Polymeric “smart” coatings to prevent foreign body response to implantable biosensors. Journal of Controlled Release, 2013, 169(3): 341–347
https://doi.org/10.1016/j.jconrel.2012.12.028
66 N Tipnis, M Kastellorizios, A Legassey, F Papadimitrakopoulos, F Jain, D J Burgess. Sterilization of drug-loaded composite coatings for implantable glucose biosensors. Journal of Diabetes Science and Technology, 2021, 15(3): 646–654
https://doi.org/10.1177/1932296819890620
67 J Xu, H Lee. Anti-biofouling strategies for long-term continuous use of implantable biosensors. Chemosensors (Basel, Switzerland), 2020, 8(3): 66
https://doi.org/10.3390/chemosensors8030066
68 M Kastellorizios, F Papadimitrakopoulos, D J Burgess. Multiple tissue response modifiers to promote angiogenesis and prevent the foreign body reaction around subcutaneous implants. Journal of Controlled Release, 2015, 214: 103–111
https://doi.org/10.1016/j.jconrel.2015.07.021
69 C F Price, D J Burgess, M Kastellorizios. L-DOPA as a small molecule surrogate to promote angiogenesis and prevent dexamethasone-induced ischemia. Journal of Controlled Release, 2016, 235: 176–181
https://doi.org/10.1016/j.jconrel.2016.05.065
70 S G Vallejo-Heligon, B Klitzman, W M Reichert. Characterization of porous, dexamethasone-releasing polyurethane coatings for glucose sensors. Acta Biomaterialia, 2014, 10(11): 4629–4638
https://doi.org/10.1016/j.actbio.2014.07.019
71 K Jiang, J D Weaver, Y Li, X Chen, J Liang, C L Stabler. Local release of dexamethasone from macroporous scaffolds accelerates islet transplant engraftment by promotion of anti-inflammatory M2 macrophages. Biomaterials, 2017, 114: 71–81
https://doi.org/10.1016/j.biomaterials.2016.11.004
72 D Paul, S Achouri, Y Z Yoon, J Herre, C E Bryant, P Cicuta. Phagocytosis dynamics depends on target shape. Biophysical Journal, 2013, 105(5): 1143–1150
https://doi.org/10.1016/j.bpj.2013.07.036
73 R J Soto, B J Privett, M H Schoenfisch. In vivo analytical performance of nitric oxide-releasing glucose biosensors. Analytical Chemistry, 2014, 86(14): 7141–7149
https://doi.org/10.1021/ac5017425
74 K H Cha, X Wang, M E Meyerhoff. Nitric oxide release for improving performance of implantable chemical sensors—a review. Applied Materials Today, 2017, 9: 589–597
https://doi.org/10.1016/j.apmt.2017.10.002
75 R Chang, G Faleo, H A Russ, A V Parent, S K Elledge, D A Bernards, J L Allen, K Villanueva, M Hebrok, Q Tang, T A Desai. Nanoporous immunoprotective device for stem-cell-derived beta-cell replacement therapy. ACS Nano, 2017, 11(8): 7747–7757
https://doi.org/10.1021/acsnano.7b01239
76 M C Frost, M M Reynolds, M E Meyerhoff. Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contactincy medical devices. Biomaterials, 2005, 26(14): 1685–1693
https://doi.org/10.1016/j.biomaterials.2004.06.006
77 D P Arora, S Hossain, Y Xu, E M Boon. Nitric oxide regulation of bacterial biofilms. Biochemistry, 2015, 54(24): 3717–3728
https://doi.org/10.1021/bi501476n
78 Y N Chou, Y Chang, T C Wen. Applying thermosettable zwitterionic copolymers as general fouling-resistant and thermal-tolerant biomaterial interfaces. ACS Applied Materials & Interfaces, 2015, 7(19): 10096–10107
https://doi.org/10.1021/acsami.5b01756
79 E Mariani, G Lisignoli, R M Borzi, L Pulsatelli. Biomaterials: foreign bodies or tuners for the immune response?. International Journal of Molecular Sciences, 2019, 20(3): 636
https://doi.org/10.3390/ijms20030636
80 N J Walters, E Gentleman. Evolving insights in cell-matrix interactions: elucidating how non-soluble properties of the extracellular niche direct stem cell fate. Acta Biomaterialia, 2015, 11: 3–16
https://doi.org/10.1016/j.actbio.2014.09.038
81 K L Helton, B D Ratner, N A Wisniewski. Biomechanics of the sensor-tissue interface-effects of motion, pressure, and design on sensor performance and the foreign body response-part I: theoretical framework. Journal of Diabetes Science and Technology, 2011, 5(3): 632–646
https://doi.org/10.1177/193229681100500317
82 A U Ernst, L H Wang, M Ma. Islet encapsulation. Journal of Materials Chemistry. B, Materials for Biology and Medicine, 2018, 6(42): 6705–6722
https://doi.org/10.1039/C8TB02020E
83 Y A Mørch, I Donati, B L Strand, G Skjak-Braek. Effect of Ca2+, Ba2+, and Sr2+ on alginate microbeads. Biomacromolecules, 2006, 7(5): 1471–1480
https://doi.org/10.1021/bm060010d
84 D M Higgins, R J Basaraba, A C Hohnbaum, E J Lee, D W Grainger, M Gonzalez-Juarrero. Localized immunosuppressive environment in the foreign body response to implanted biomaterials. American Journal of Pathology, 2009, 175(1): 161–170
https://doi.org/10.2353/ajpath.2009.080962
85 M O Dellacherie, B R Seo, D J Mooney. Macroscale biomaterials strategies for local immunomodulation. Nature Reviews. Materials, 2019, 4(6): 379–397
https://doi.org/10.1038/s41578-019-0106-3
86 S N Christo, K R Diener, A Bachhuka, K Vasilev, J D Hayball. Innate immunity and biomaterials at the nexus: friends or foes. BioMed Research International, 2015, 2015: 342304
https://doi.org/10.1155/2015/342304
87 P de Candia, F Prattichizzo, S Garavelli, V De Rosa, M Galgani, F Di Rella, M I Spagnuolo, A Colamatteo, C Fusco, T Micillo, S Bruzzaniti, A Ceriello, A A Puca, G Matarese. Type 2 diabetes: how much of an autoimmune disease?. Frontiers in Endocrinology (Lausanne), 2019, 10: 451
https://doi.org/10.3389/fendo.2019.00451
88 W Chen, B C Yung, Z Qian, X Chen. Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction. Advanced Drug Delivery Reviews, 2018, 127: 20–34
https://doi.org/10.1016/j.addr.2018.01.016
89 R A S Nascimento, M Mulato. Microelectronic sensor for continuous glucose monitoring. Applied Physics. A, Materials Science & Processing, 2019, 125(3): 175
https://doi.org/10.1007/s00339-019-2455-6
90 H Lee, Y J Hong, S Baik, T Hyeon, D H Kim. Enzyme-based glucose sensor: from invasive to wearable device. Advanced Healthcare Materials, 2018, 7(8): 1701150
https://doi.org/10.1002/adhm.201701150
91 G Marchioli, L van Gurp, P P van Krieken, D Stamatialis, M Engelse, C A van Blitterswijk, M B J Karperien, E de Koning, J Alblas, L Moroni, A A van Apeldoorn. Fabrication of three-dimensional bioplotted hydrogel scaffolds for islets of Langerhans transplantation. Biofabrication, 2015, 7(2): 025009
https://doi.org/10.1088/1758-5090/7/2/025009
92 Y Lee, N Matsushima, S Yada, S Nita, T Kodama, G Amberg, J Shiomi. Revealing how topography of surface microstructures alters capillary spreading. Scientific Reports, 2019, 9(1): 7787
https://doi.org/10.1038/s41598-019-44243-x
93 T L Hanson, C A Diaz-Botia, V Kharazia, M M Maharbiz, P N Sabes. The “sewing machine” for minimally invasive neural recording. BioRxiv, 2019, 578542
https://doi.org/10.1101/578542
94 C L Stabler, Y Li, J M Stewart, B C Keselowsky. Engineering immunomodulatory biomaterials for type 1 diabetes. Nature Reviews. Materials, 2019, 4(6): 429–450
https://doi.org/10.1038/s41578-019-0112-5
95 P T J Hwang, D K Shah, J A Garcia, C Y Bae, D J Lim, R C Huiszoon, G C Alexander, H W Jun. Progress and challenges of the bioartificial pancreas. Nano Convergence, 2016, 3(1): 28
https://doi.org/10.1186/s40580-016-0088-4
96 A J Guseman, S L Speer, G M Perez Goncalves, G J Pielak. Surface charge modulates protein-protein interactions in physiologically relevant environments. Biochemistry, 2018, 57(11): 1681–1684
https://doi.org/10.1021/acs.biochem.8b00061
97 E J Shin, S M Choi. Advances in waterborne polyurethane-based biomaterials for biomedical applications. Advances in Experimental Medicine and Biology, 2018, 1077: 251–283
https://doi.org/10.1007/978-981-13-0947-2_14
98 Y Cai, B Liang, S Chen, Q Zhu, T Tu, K Wu, Q Cao, L Fang, X Liang, X Ye. One-step modification of nano-polyaniline/glucose oxidase on double-side printed flexible electrode for continuous glucose monitoring: characterization, cytotoxicity evaluation and in vivo experiment. Biosensors & Bioelectronics, 2020, 165: 112408
https://doi.org/10.1016/j.bios.2020.112408
99 S Campuzano, M Pedrero, P Yanez-Sedeno, J M Pingarron. Antifouling (bio)materials for electrochemical (bio)sensing. International Journal of Molecular Sciences, 2019, 20(2): 423
https://doi.org/10.3390/ijms20020423
100 I Francolini, C Vuotto, A Piozzi, G Donelli. Antifouling and antimicrobial biomaterials: an overview. Acta Pathologica et Microbiologica Scandinavica. Supplement, 2017, 125(4): 392–417
https://doi.org/10.1111/apm.12675
101 M Liu, Y Xu, Y Zhao, Z Wang, D Shi. Hydroxyl radical-involved cancer therapy via Fenton reactions. Frontiers of Chemical Science and Engineering, 2022, 16(3): 345–363
https://doi.org/10.1007/s11705-021-2077-3
102 X Mu, Y Xu, Z Wang, D Shi. Probes and nano-delivery systems targeting NAD(P)H: quinone oxidoreductase 1: a mini-review. Frontiers of Chemical Science and Engineering, 2023, 17(2): 123–138
https://doi.org/10.1007/s11705-022-2194-7
103 J Wu, W Lin, Z Wang, S Chen, Y Chang. Investigation of the hydration of nonfouling material poly(sulfobetaine methacrylate) by low-field nuclear magnetic resonance. Langmuir, 2012, 28(19): 7436–7441
https://doi.org/10.1021/la300394c
104 S Jiang, Z Cao. Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications. Advanced Materials, 2010, 22(9): 920–932
https://doi.org/10.1002/adma.200901407
105 G Cheng, G Li, H Xue, S Chen, J D Bryers, S Jiang. Zwitterionic carboxybetaine polymer surfaces and their resistance to long-term biofilm formation. Biomaterials, 2009, 30(28): 5234–5240
https://doi.org/10.1016/j.biomaterials.2009.05.058
106 Z Zhang, S Chen, Y Chang, S Jiang. Surface grafted sulfobetaine polymers via atom transfer radical polymerization as superlow fouling coatings. Journal of Physical Chemistry B, 2006, 110(22): 10799–10804
https://doi.org/10.1021/jp057266i
107 W Feng, J L Brash, S P Zhu. Non-biofouling materials prepared by atom transfer radical polymerization grafting of 2-methacryloloxyethyl phosphorylcholine: separate effects of graft density and chain length on protein repulsion. Biomaterials, 2006, 27(6): 847–855
https://doi.org/10.1016/j.biomaterials.2005.07.006
108 A B Lowe, C L McCormick. Synthesis and solution properties of zwitterionic polymers. Chemical Reviews, 2002, 102(11): 4177–4190
https://doi.org/10.1021/cr020371t
109 S Chen, L Li, C Zhao, J Zheng. Surface hydration: principles and applications toward low-fouling/nonfouling biomaterials. Polymer, 2010, 51(23): 5283–5293
https://doi.org/10.1016/j.polymer.2010.08.022
110 F Xuan, J Liu. Preparation, characterization and application of zwitterionic polymers and membranes: current developments and perspective. Polymer International, 2009, 58(12): 1350–1361
https://doi.org/10.1002/pi.2679
111 S F Chen, J Zheng, L Y Li, S Y Jiang. Strong resistance of phosphorylcholine self-assembled monolayers to protein adsorption: insights into nonfouling properties of zwitterionic materials. Journal of the American Chemical Society, 2005, 127(41): 14473–14478
https://doi.org/10.1021/ja054169u
112 M He, K Gao, L Zhou, Z Jiao, M Wu, J Cao, X You, Z Cai, Y Su, Z Jiang. Zwitterionic materials for antifouling membrane surface construction. Acta Biomaterialia, 2016, 40: 142–152
https://doi.org/10.1016/j.actbio.2016.03.038
113 R Jayakumar, M Prabaharan, P T Sudheesh Kumar, S V Nair, H Tamura. Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnology Advances, 2011, 29(3): 322–337
https://doi.org/10.1016/j.biotechadv.2011.01.005
114 R Jayakumar, M Prabaharan, S V Nair, H Tamura. Novel chitin and chitosan nanofibers in biomedical applications. Biotechnology Advances, 2010, 28(1): 142–150
https://doi.org/10.1016/j.biotechadv.2009.11.001
115 F Robotti, S Bottan, F Fraschetti, A Mallone, G Pellegrini, N Lindenblatt, C Starck, V Falk, D Poulikakos, A Ferrari. A micron-scale surface topography design reducing cell adhesion to implanted materials. Scientific Reports, 2018, 8(1): 10887
https://doi.org/10.1038/s41598-018-29167-2
116 S Franz, S Rammelt, D Scharnweber, J C Simon. Immune responses to implants—a review of the implications for the design of immunomodulatory biomaterials. Biomaterials, 2011, 32(28): 6692–6709
https://doi.org/10.1016/j.biomaterials.2011.05.078
117 J S Lewis, K Roy, B G Keselowsky. Materials that harness and modulate the immune system. MRS Bulletin, 2014, 39(1): 25–34
https://doi.org/10.1557/mrs.2013.310
118 V B Damodaran, N S Murthy. Bio-inspired strategies for designing antifouling biomaterials. Biomaterials Research, 2016, 20(1): 18
https://doi.org/10.1186/s40824-016-0064-4
119 A Espinoza-Jiménez, A N Peon, L I Terrazas. Alternatively activated macrophages in types 1 and 2 diabetes. Mediators of Inflammation, 2012, 2012: 815593
https://doi.org/10.1155/2012/815953
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed